Sinopharm Holding Meizhou Co., Ltd. announced that it will receive CNY 16,800,000 in equity funding from existing investor China National Accord Medicines Corporation Ltd. on October 8, 2014. The registered capital of the company will increase to CNY 18,000,000 after the transaction. The transaction has been approved at the 2nd session of the 7th directorate meeting of the investor.

The transaction requires the approval from its 3rd special stockholders' meeting of 2014. The investor will continue to hold 100% stake in the company after the transaction. The company reported total assets of CNY 73,310,000, net assets of CNY 4,450,000, and revenue of CNY 138,460,000 for the year ended December 31, 2013.